Delivery Order SPE2D018D0005-SPE2D325F291M
Award Date 8/5/25
Potential Completion Date 8/8/25
Potential Value $1.8K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Department's Medical Supply Chain agency awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-B Bioclone 15x10ML on August 11, 2025, with completion targeted for August 14, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, headquartered in Raritan, New Jersey, is a for-profit medical equipment manufacturer specializing...
- Ortho-Clinical Diagnostics, Inc. has been awarded a delivery order contract by the Defense Medical Supply Chain with a ceiling value of $1,767.32 for Rght Anti-A B Bcln 10ml Btl Orth Bb—a specialized blood bank diagnostic reagent. The contract award is dated July 18, 2025, with an ultimate completion date of July 30, 2025, and will be performed at the company's facility in Raritan, New Jersey. This delivery order employs fixed-price contracting with economic price adjustment and was awarded...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $1,963.68 by the Defense Medical Supply Chain on August 5, 2025, for Rgt Anti-A B Bcln 10mL bottles used in orthopedic blood bank applications. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating open competition, and carries an ultimate completion date of August 8, 2025. Performance will be conducted at the awardee's facility in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order valued at $1,109.97 to Ortho-Clinical Diagnostics, Inc. for Anti-A Bioclone 15x10ML on August 1, 2025, with an ultimate completion date of August 6, 2025. The contract utilizes fixed-price pricing with economic price adjustment and carries no set-aside designation, indicating open competition. Performance will occur at the contractor's facility in Raritan, New Jersey. Ortho-Clinical Diagnostics, Inc., a for-profit...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $1,871.28 for Anti-A Bioclone 15x10ml on July 21, 2025, with an ultimate completion date of July 24, 2025. The contract utilizes fixed-price pricing with economic price adjustment and was awarded without a set-aside designation, indicating open competition. The work will be performed in Raritan, New Jersey, and is funded by the Defense Health Agency's Medical Supply Chain, which supports critical medical diagnostic...
- Ortho-Clinical Diagnostics, Inc., headquartered in Raritan, New Jersey, was awarded a delivery order valued at $1,910.02 on August 6, 2025, for Anti-A Bioclone 15x10ml medical diagnostic reagents. The contract, which will be completed by August 27, 2025, was issued without a set-aside designation, indicating open competition. The funding originates from the Medical Supply Chain within the Department of Defense, with the place of performance located in Raritan, New Jersey. This delivery order...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order valued at $2,074.46 by the Defense Health Agency's Medical Supply Chain on August 5, 2025, for the supply of Rh antigen anti-D blood bank reagent in 150ml monoclonal ABO group format. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Performance is scheduled for completion by August 8, 2025, at the contractor's facility in Raritan, New Jersey. This delivery order represents a...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order on August 6, 2025, by the Defense Medical Supply Chain to supply ANTI-A BioclOne 15x10mL, a diagnostic reagent product. The contract is valued at $1,109.97 under a fixed-price arrangement with economic price adjustment provisions, with an ultimate completion date of August 11, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was utilized for this award, indicating open...
- Ortho-Clinical Diagnostics, Inc. was awarded a delivery order contract on July 11, 2025, by the Medical Supply Chain division of the Department of Defense for the supply of Anti-A Bioclone 15x10ml reagents, valued at $1,156.61. The contract employs fixed-price pricing with economic price adjustment provisions and is scheduled for ultimate completion by August 1, 2025. The work will be performed at the company's facility in Raritan, New Jersey. No set-aside designation was used in this...
- This is a delivery order contract awarded by the Medical Supply Chain, a component of the Department of Defense, to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $3,927.36 firm fixed-price contract is for the delivery of ORTHO BCLN 10ML BTL, a type of blood bank reagent, with a performance period ending on July 7, 2025. The contract does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...